DUBLIN--(BUSINESS WIRE)--The "Europe Alzheimer's Disease Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.
The research provides insights into Alzheimer's Disease epidemiology, Alzheimer's Disease diagnosed patients, and Alzheimer's Disease treatment rate for EU5 countries. The research measures key indicators including prevalence of Alzheimer's Disease derived from epidemiological analysis, patients diagnosed with Alzheimer's Disease, and patients treated with a drug therapy.
The research study helps executives estimate Alzheimer's Disease market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The research provides estimates and forecasts of Alzheimer's Disease prevalence, Alzheimer's Disease diagnosis rate, and Alzheimer's Disease treatment rate for the period 2017 - 2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.
Key Topics Covered:
1. Alzheimer's Disease: Disease Definition
2. Alzheimer's Disease Patient Flow in Europe
3. Alzheimer's Disease Patient Flow in Germany
4. Alzheimer's Disease Patient Flow in France
5. Alzheimer's Disease Patient Flow in Spain
6. Alzheimer's Disease Patient Flow in Italy
7. Alzheimer's Disease Patient Flow in UK
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/research/q8wccl/europe?w=4
